Antengene

Antengene's reported carbon emissions

Antengene, a pharmaceutical preparation manufacturer headquartered in China, reported approximately 1,170,000 kg CO2e in total emissions for the year 2023. This figure encompasses Scope 1 and Scope 2 emissions, amounting to approximately 45,220 kg CO2e and 1,124,760 kg CO2e, respectively. In 2022, the company's total emissions were approximately 1,613,260 kg CO2e, with Scope 1 emissions around 551,320 kg CO2e and Scope 2 emissions at approximately 1,061,940 kg CO2e. For 2021, Antengene reported total Scope 1 and 2 emissions of approximately 994,380 kg CO2e, comprising about 27,080 kg CO2e for Scope 1 and around 967,300 kg CO2e for Scope 2. In 2020, the company's Scope 1 and 2 emissions totalled approximately 278,470 kg CO2e, with Scope 1 emissions at about 27,080 kg CO2e and Scope 2 emissions at approximately 251,390 kg CO2e. Antengene's sustainability reports also provide emission intensity metrics per square meter and per employee. For 2023, GHG emission intensity was approximately 50 kg CO2e per square meter and 6,430 kg CO2e per employee. In 2022, the intensity was approximately 70 kg CO2e per square meter and 7,230 kg CO2e per employee. For 2021, GHG emission intensity was approximately 50 kg CO2e for 'other' and 5,290 kg CO2e per employee. In 2020, GHG emission intensity was approximately 15 kg CO2e per square meter. Antengene has not disclosed Scope 3 emissions data for the reported years and does not currently have specific reduction targets or commitments documented, such as those from SBTi or the Climate Pledge.